GeneXpert Ultra- a New Diagnostic Era for Childhood Tuberculosis

Tahmida Haque, D. Hossain, T. Islam
{"title":"GeneXpert Ultra- a New Diagnostic Era for Childhood Tuberculosis","authors":"Tahmida Haque, D. Hossain, T. Islam","doi":"10.36347/sajb.2022.v10i11.001","DOIUrl":null,"url":null,"abstract":"Introduction: Tuberculosis (TB) is a serious public health problem and a significant diagnostic and therapeutic challenge worldwide. Molecular diagnostic techniques are crucial in the World Health Organization’s new tubercular control strategy. Objective: The study aims to investigate the efficacy of GeneXpert Ultra in the diagnosis of childhood tuberculosis. Methods: A prospective cross-sectional study was carried out in the pediatric pulmonology ward and general pediatric ward of the Institute of Child and Mother Health (ICMH), Matuail, Dhaka. Child ages ranging from two months to fifteen years who were admitted to the pediatric pulmonology ward and general pediatric ward of ICMH during the period of December 2020 to November 2021 with a history of fever, cough, chest pain, evening rise of temperature, night sweats, weight loss were included in this study. Results: Among the study population (N=99), almost all the patients (91, 91.2%) had cough, thirty-six patients (36, 36.3%) had cough for 2 weeks, and about half of the patients (49, 49.5%) had a productive cough, ninety patients (90, 90.9%) had fever, around one-fifth of the patients, had a fever more than two weeks. About half of the patients (47, 47.5%) had a high-grade intermittent fever. Evening rise of temperature was seen in around one-fourth of the patients (24, 24.2%). MT test was positive for two patients (2, 2.0%) and doubtful for two patients (2, 2.0%)., Seventeen patients (17, 17.1%) specimens were collected from induced sputum, around three-fifths of the patients’ (70, 70.7%) specimens were collected from gastric aspirate, eighty-two patients (82, 82.8%) specimens were collected from the stool and one patient’s specimen (1, 1.0%)was collected from pus produced in BCG vaccine site. GeneXpert ultra was detected in thirteen patients (13, 13.1%) and was trace detected in six patients (6, 6.0%). Of the 13 patients, 7 patients (7, 53.8%) were diagnosed with pulmonary TB, two patients (2, 15.4%) were .....","PeriodicalId":199401,"journal":{"name":"Scholars Academic Journal of Biosciences","volume":"65 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scholars Academic Journal of Biosciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36347/sajb.2022.v10i11.001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Tuberculosis (TB) is a serious public health problem and a significant diagnostic and therapeutic challenge worldwide. Molecular diagnostic techniques are crucial in the World Health Organization’s new tubercular control strategy. Objective: The study aims to investigate the efficacy of GeneXpert Ultra in the diagnosis of childhood tuberculosis. Methods: A prospective cross-sectional study was carried out in the pediatric pulmonology ward and general pediatric ward of the Institute of Child and Mother Health (ICMH), Matuail, Dhaka. Child ages ranging from two months to fifteen years who were admitted to the pediatric pulmonology ward and general pediatric ward of ICMH during the period of December 2020 to November 2021 with a history of fever, cough, chest pain, evening rise of temperature, night sweats, weight loss were included in this study. Results: Among the study population (N=99), almost all the patients (91, 91.2%) had cough, thirty-six patients (36, 36.3%) had cough for 2 weeks, and about half of the patients (49, 49.5%) had a productive cough, ninety patients (90, 90.9%) had fever, around one-fifth of the patients, had a fever more than two weeks. About half of the patients (47, 47.5%) had a high-grade intermittent fever. Evening rise of temperature was seen in around one-fourth of the patients (24, 24.2%). MT test was positive for two patients (2, 2.0%) and doubtful for two patients (2, 2.0%)., Seventeen patients (17, 17.1%) specimens were collected from induced sputum, around three-fifths of the patients’ (70, 70.7%) specimens were collected from gastric aspirate, eighty-two patients (82, 82.8%) specimens were collected from the stool and one patient’s specimen (1, 1.0%)was collected from pus produced in BCG vaccine site. GeneXpert ultra was detected in thirteen patients (13, 13.1%) and was trace detected in six patients (6, 6.0%). Of the 13 patients, 7 patients (7, 53.8%) were diagnosed with pulmonary TB, two patients (2, 15.4%) were .....
GeneXpert Ultra——儿童结核病的新诊断时代
结核病(TB)是一个严重的公共卫生问题,也是世界范围内重大的诊断和治疗挑战。分子诊断技术在世界卫生组织新的结核病控制战略中至关重要。目的:探讨GeneXpert Ultra在儿童结核病诊断中的应用价值。方法:在达卡Matuail妇幼保健研究所(ICMH)的儿科肺科病房和普通儿科病房进行前瞻性横断面研究。本研究纳入了2020年12月至2021年11月期间入住ICMH儿科肺科病房和普通儿科病房,年龄在2个月至15岁之间,有发热、咳嗽、胸痛、夜间体温升高、盗汗、体重减轻史的儿童。结果:研究人群(N=99)中,几乎所有患者(91,91.2%)咳嗽,36例患者(36,36.3%)咳嗽持续2周,约一半患者(49,49.5%)咳出性咳嗽,90例患者(90,90.9%)发烧,约五分之一的患者发烧超过2周。大约一半的患者(47,47.5%)有高度间断性发热。大约四分之一的患者(24.2%,24.2%)出现夜间体温升高。MT阳性2例(2,2.0%),可疑2例(2,2.0%)。诱导痰标本17例(17.1%),胃吸痰标本70例(70.7%),粪便标本82例(82,82.8%),卡介苗部位脓液标本1例(1,1.0%)。在13例(13.1%)患者中检测到GeneXpert ultra,在6例(6.0%)患者中检测到微量。13例患者中,7例(7.53.8%)诊断为肺结核,2例(2.15.4%)为.....
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信